BDNF is a key player in mechanisms of synaptic plasticity underlying the therapeutic efficacy of antidepressants (reviewed by Björkholm and Monteggia, 2016; Yang et al., 2020), and plasma BDNF levels are enhanced in patients affected by MDD responding to medication (Zhou et al., 2017). This evidence concerns the gene BDNF and major depressive disorder.